Prevalence of Irritable Bowel Syndrome in Japan, China, and South Korea: An International Cross-sectional Study

Abstract

Background/AimsSymptoms of irritable bowel syndrome (IBS), a common gut-brain interaction disorder, deteriorate patients' quality of life and increase medical needs; therefore, IBS represents a significant global burden. The estimated global prevalence is approximately 10%; however, accumulated evidence shows international heterogeneity. In this study, we have described and compared the prevalence of IBS in 3 East Asian countries: Japan (Tokyo and Fukuoka), China (Beijing), and South Korea (Seoul). MethodsWe conducted an internet-based cross-sectional survey of the urban population aged > 20 years in the abovementioned countries. We recruited equal numbers of age-(20s-60s) and sex-matched participants (3910 residents). IBS was diagnosed according to the Rome III criteria, and the subtypes were analyzed. ResultsThe overall prevalence of IBS with 95% CI was 12.6% (11.6-13.7); the prevalence was significantly different across Japan, China,, respectively) (P < 0.001). Furthermore, 54.9% of patients were male. IBS-mixed was the most prevalent subtype; the prevalence of other subtypes varied. ConclusionsThe overall prevalence of IBS in the 3 countries was slightly higher than the global prevalence, and it was significantly lower in China than in Japan and South Korea. IBS prevalence was the highest and lowest among individuals in their 40s and 60s, respectively. Male individuals had a higher prevalence of IBS with diarrhea. Further studies are needed to elucidate the factors associated with this regional heterogeneity.

Prevalence of Irritable Bowel Syndrome in Saudi Arabia: A Systematic Review and Meta-Analysis

“…However, the prevalence substantially varied between countries worldwide, and the reason still needs to be identified [ 2 ]. A 2023 study reported that the prevalence from Japan, China, and South Korea was reported as 14.9%, 5.5%, and 15.6%, respectively, with a 54.9% male population [ 48 ]. An SR by Al-baghli et al based on Saudi studies reported that the IBS prevalence ranged from 7.9% to 40.7% [ 49 ].…”

“…The 38 studies were based on both-gender, male-only, and female-only studies. Nevertheless, the gender predominance is still not concluded [ 47 , 48 ]; however, a higher prevalence was reported for females [ 3 ].…”

Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis

“…With the changing times, the burden of life and work has increased, and the diets and rest patterns of individuals have become extremely irregular, which can easily induce IBS. A recent international cross-sectional study reported that the overall prevalence of IBS in East Asia was 12.6% [ 6 ]. Although IBS is not fatal, it seriously affects health and quality of life and imposes a heavy financial burden on families and social healthcare [ 7 ].…”

Mind the Gap: The Realities of Novel Irritable Bowel Syndrome Drug Access in Asian Clinical Practice

“… 1 The overall prevalence of IBS in a recent study in East Asia, including Japan, China, and South Korea, using Rome III criteria was slightly higher than the global prevalence, and male patients comprised 54.9% of the cases. 2 IBS is associated with a significant financial burden on healthcare and adversely affects patients’ quality of life. 3 With these challenges, there is an urgent need to develop and implement novel IBS drugs.…”